S. Peaker

发表

Poor Compliance Is a Major Factor in Unstable Outpatient Control of Anticoagulant Therapy

S. Kumar, M. Feely, L. Rhodes, 1989, Thrombosis and Haemostasis.

Use of a pharmacological indicator to monitor compliance with thyroxine

M. Feely, A. Griffiths, N. D. Penn, 2004, European Journal of Clinical Pharmacology.

Sensitivity of the receptors for salt-gland secretion in the domestic duck and goose.

M. Peaker, J. Linzell, S. Peaker, 1973, Comparative biochemistry and physiology. A, Comparative physiology.

Absorption of Tritiated Water by the Cloaca of the Domestic Duck (Anas platyrhynchos)

M. Peaker, J. Phillips, A. Wright, 1968, Physiological Zoology.

The effects of corticotrophin, glucose and potassium chloride on secretion by the nasal salt gland of the duck, Anas platyrhynchos.

M. Peaker, J. Phillips, A. Wright, 1971, The Journal of endocrinology.

Rapid gas chromatographic determination of dimethyl sulphoxide and its metabolite dimethyl sulphone in plasma and urine.

A. C. Mehta, R. Calvert, S. Peaker, 1986, Journal of chromatography.

A comparison of a short half-life marker (low-dose isoniazid), a long half-life pharmacological indicator (low-dose phenobarbitone) and measurements of a controlled release 'therapeutic drug' (metoprolol, Metoros) in reflecting incomplete compliance by volunteers.

T. Pullar, S. Kumar, M. Feely, 1990, British journal of clinical pharmacology.

Measurement of low (sub-therapeutic) phenobarbitone levels in plasma by high-performance liquid chromatography: application to patient compliance studies.

A. C. Mehta, S. Kumar, M. Feely, 1989, Journal of chromatography.

Pharmacokinetics of N-desmethylclobazam in healthy volunteers and patients with epilepsy.

T. Pullar, M. Feely, J. Haigh, 1987, British journal of clinical pharmacology.

The effect of cimetidine on the single dose pharmacokinetics of oral clobazam and N-desmethylclobazam.

T. Pullar, M. Feely, J. Haigh, 1987, British journal of clinical pharmacology.

The prediction of steady-state plasma phenobarbitone concentrations (following low-dose phenobarbitone) to refine its use as an indicator of compliance.

H. Chrystyn, T. Pullar, S. Kumar, 1991, British journal of clinical pharmacology.